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A major challenge in translating the promise of stem cell therapies to treat a myriad of 
neurodegenerative disorders is to rapidly and efﬁciently direct pluripotent stem cells to 
generate differentiated neurons. The application of active vitamin metabolites known to 
function in embryonic development and maintenance in the adult brain such as retinoic 
acid (vitamin A), ascorbic acid (vitamin C) and calcitriol (vitamin D3) have proven effective 
in current in-vitro differentiation protocols. 
Therefore, in this study we investigated whether the biologically active vitamin B3 
metabolite, nicotinamide could enhance the differentiation of mouse embryonic stem 
cells, cultured as monolayers, into mature neurons at either early or late stages of 
development. 
Interestingly, nicotinamide elicited a dose-responsive increase in the percentage of neurons 
when added at an early develop- mental stage to the cells undergoing differentiation 
(days 0–7). Nicotinamide (10 mM) increased the proportion of β-III tubulin positive 
neurons by two fold and concomitantly decreased the total number of cells in culture, 
measured by quantiﬁcation of 4', 6-diamidino-2-phenylindole positive cells. This effect could 
result from induction of cell-cycle exit and/or selective cell death in non-neural populations. 
Higher levels of nicotinamide (20 mM) induced cytoxicity and cell death. 
This study supports previous evidence that vitamins and their metabolites can efﬁciently 
direct stem cells into neurons. Current work is focusing on the effect of nicotinamide on 
the process of neural induction and whether nicotinamide inﬂu-ences the generation 
of particular neuronal subtypes implicated in neurodegenerative diseases, speciﬁcally 
focusing on midbrain dopamine neurons; towards a therapy for Parkinson’s disease.  
